Modalis Therapeutics Corporation
Loading...
Key Metrics
Market Cap
N/A
P/E Ratio
N/A
P/B Ratio
N/A
Revenue
N/A
Net Income
-1.3B
Gross Margin
N/A
Op. Margin
N/A
Net Margin
N/A
ROE
-37.1%
ROA
-35.7%
D/E
0.04
Dividend Yield
N/A
EPS
-28.57
Current Ratio
30.83
Price History
Company Info
| Industry | PHARMACEUTICAL |
| Market Segment | Growth |
| Accounting | Japan GAAP |
| Currency | JPY |
| Fiscal Year | 2024 |
Peers
GNI Group Ltd.
2160
--
P/E: --
Kyowa Kirin Co.,Ltd.
4151
--
P/E: --
--
P/E: --
Astellas Pharma Inc.
4503
--
P/E: --
--
P/E: --
Shionogi & Co.,Ltd.
4507
--
P/E: --
--
P/E: --
--
P/E: --
Financial Statements
Loading financials...
Open Advanced Charts
Full charting with technical indicators, candlestick, and more.
| Ticker | 4883 |
| Exchange | TSE |
| Sector | Pharmaceutical |
| Industry | PHARMACEUTICAL |